Crestline Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,121
Closed -$343K 549
2024
Q4
$343K Buy
+7,121
New +$362K 0.01% 601
2021
Q3
Sell
-19,731
Closed -$1.04M 262
2021
Q2
$1.04M Buy
+19,731
New +$1.03M 0.09% 99

Other funds holding SNY

Crestline Management's SNY Position: Q1 2025 in Review

Crestline Management sold out of Sanofi (SNY) in Q1 2025, closing a stake of 7,121 shares — an estimated $343K sold.

Crestline Management first reported a position in SNY in Q2 2021 and held it in 2 quarters. The position peaked at $1.04M in Q2 2021. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Crestline Management reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 7,121 Sanofi shares in Q1 2025, an estimated $343K.
  • Crestline Management first reported a position in Sanofi in Q2 2021 and held it in 2 quarters.
  • Crestline Management's Sanofi position peaked at $1.04M in Q2 2021.
  • 771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.